NucleaseDAO
NucleaseDAO
Genomics Research

Accelerating breakthroughs in genomics research and CRISPR. Partnering with labs to design and optimize CRISPR-Cas9 experiments, we’re fostering a decentralized ecosystem for cutting-edge research. NuDAO empowers a global community of scientists, supporters, and token holders to direct funding and governance in the emerging field of genomics.

Learn more:

Market Hypothesis

$16.5 Billion

CRISPR Gene Editing Market Value by 2028

2

CRISPR therapies approved by FDA only so far

$500 Billion

in saved healthcare systems costs annually through personalized medicine

CRISPR and emerging genetic technology have massive potential yet the research is progressing too slowly and worthy science isn’t getting funding.


We're building a revolutionary way to fund and advance CRISPR research through a groundbreaking two-token system. $NUDAO holders govern research priorities, funding, and value distribution, ensuring every decision is strategic, real-time, and community-driven to benefit all token holders. Our vision is a world where decentralized collaboration fosters transparency, adaptability, and meaningful impact. Join us in building an ecosystem where innovation thrives and every voice shapes the future.


Join a community where research success directly translates to holder value, guided by careful DAO governance. Whether you want to help direct the future of CRISPR research or benefit from its success, there's a place for you in our ecosystem.

Team & Community
Julia Dovga

Julia Dovga

Researcher at Francis Crick Institute

Senior Research Scientist in Cancer Dynamics Group.

Emmanuel Bijaoui

Emmanuel Bijaoui

Dementia & Microbiome researcher

Founder & CEO @ Treat Therapeutics (Pet CRO), prev Dementia & Microbiome researcher.

SkyCat

SkyCat

AI Dev.

Partner at AI16Z .

@Nuclease_DAO on 𝕏

Discord community

Telegram community